Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Mem. Inst. Oswaldo Cruz ; 96(suppl): 157-164, Sept. 2001. tab
Article Dans Anglais | LILACS | ID: lil-295894

Résumé

Praziquantel was given every eight weeks for two years to children aged under six years of age, living in a Schistosoma haematobium endemic area. Infection with S. haematobium and haematuria were examined in urine and antibody profiles (IgA, IgE, IgM, IgG1, IgG2, IgG3, and IgG4) against S. haematobium adult worm and egg antigens were determined from sera collected before each treatment. Chemotherapy reduced infection prevalence and mean intensity from 51.8 percent and 110 eggs per 10 ml urine, respectively, before starting re-treatment programme to very low levels thereafter. Praziquantel is not accumulated after periodic administration in children. Immunoglobulin levels change during the course of treatment with a shift towards 'protective' mechanisms. The significant changes noted in some individuals were the drop in 'blocking' IgG2 and IgG4 whereas the 'protecting' IgA and IgG1 levels increased. The antibody profiles in the rest of the children remained generally unchanged throughout the study and no haematuria was observed after the second treatment. The removal of worms before production of large number of eggs, prevented the children from developing morbidity


Sujets)
Humains , Animaux , Enfant , Anthelminthiques/usage thérapeutique , Praziquantel/usage thérapeutique , Bilharziose urinaire/traitement médicamenteux , Anticorps antihelminthe/isolement et purification , Antigènes d'helminthe/isolement et purification , Maladies endémiques , Études de suivi , Hématurie/immunologie , Récidive , Reprise du traitement , Schistosoma haematobium/immunologie , Bilharziose urinaire/épidémiologie , Bilharziose urinaire/immunologie , Facteurs temps , Zimbabwe/épidémiologie
SÉLECTION CITATIONS
Détails de la recherche